MAMOLO, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 12.017
EU - Europa 8.032
AS - Asia 6.096
SA - Sud America 653
Continente sconosciuto - Info sul continente non disponibili 514
AF - Africa 139
OC - Oceania 6
Totale 27.457
Nazione #
US - Stati Uniti d'America 11.867
IT - Italia 3.288
SG - Singapore 2.048
CN - Cina 1.601
SE - Svezia 1.324
UA - Ucraina 889
HK - Hong Kong 546
BR - Brasile 525
VN - Vietnam 508
KR - Corea 504
FR - Francia 416
FI - Finlandia 350
DE - Germania 342
PL - Polonia 336
TR - Turchia 336
RU - Federazione Russa 262
GB - Regno Unito 244
BG - Bulgaria 155
IE - Irlanda 151
IN - India 148
NL - Olanda 97
BD - Bangladesh 88
CA - Canada 70
JP - Giappone 54
AR - Argentina 48
MX - Messico 38
BE - Belgio 37
MA - Marocco 37
MY - Malesia 37
ZA - Sudafrica 36
SA - Arabia Saudita 33
CH - Svizzera 26
ES - Italia 26
EU - Europa 26
SN - Senegal 25
PK - Pakistan 23
EC - Ecuador 21
ID - Indonesia 20
IQ - Iraq 20
AT - Austria 16
CO - Colombia 15
PH - Filippine 15
CL - Cile 13
IR - Iran 13
IL - Israele 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
RO - Romania 10
TW - Taiwan 10
UZ - Uzbekistan 10
EG - Egitto 9
KE - Kenya 9
PY - Paraguay 9
UY - Uruguay 9
HR - Croazia 8
TT - Trinidad e Tobago 8
VE - Venezuela 8
GR - Grecia 7
KZ - Kazakistan 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
DK - Danimarca 6
JO - Giordania 6
TH - Thailandia 6
LT - Lituania 5
OM - Oman 5
PS - Palestinian Territory 5
SV - El Salvador 5
TN - Tunisia 5
AL - Albania 4
ET - Etiopia 4
KG - Kirghizistan 4
LV - Lettonia 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
AO - Angola 3
AU - Australia 3
BH - Bahrain 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PE - Perù 3
PR - Porto Rico 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
MK - Macedonia 2
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 26.952
Città #
Woodbridge 1.249
Singapore 1.235
Ann Arbor 1.209
Ashburn 971
Trieste 779
Jacksonville 769
San Jose 722
Houston 704
Chandler 689
Hong Kong 529
Fairfield 510
Seoul 494
Hefei 469
Beijing 428
Wilmington 426
Izmir 300
Columbus 289
Princeton 287
Dallas 272
Council Bluffs 235
Boardman 234
Milan 230
Seattle 204
Chicago 197
Warsaw 182
Ho Chi Minh City 161
Dearborn 157
Sofia 154
Los Angeles 153
Dublin 148
Cambridge 145
Lauterbourg 138
Zgierz 136
Rome 129
Buffalo 115
Hanoi 106
Moscow 95
Santa Clara 92
Helsinki 89
The Dalles 87
New York 70
Frankfurt am Main 56
Verona 52
San Diego 47
São Paulo 47
Düsseldorf 45
Tokyo 45
Munich 44
Naples 42
Phoenix 41
Turin 40
Bremen 38
Catania 38
Des Moines 37
Grafing 35
Nanjing 35
Brussels 34
Jinan 34
Orem 33
Messina 32
Redwood City 32
Bologna 31
Kunming 31
Shanghai 30
Da Nang 29
Casablanca 28
London 27
Guangzhou 26
Chennai 25
Dakar 25
Norwalk 25
Toronto 25
Atlanta 24
Bari 24
Florence 23
Cagliari 22
Mestre 21
Rio de Janeiro 21
Washington 21
Mumbai 20
Brooklyn 19
Falls Church 19
Palermo 19
Haiphong 18
Montreal 18
Perugia 17
Tianjin 17
Denver 16
New Delhi 16
Padova 16
Philadelphia 16
Brescia 15
Dammam 15
Johannesburg 15
Sacile 15
Venice 15
Bern 14
Manchester 14
Portsmouth 14
Shenyang 14
Totale 17.195
Nome #
Determinazione quantitativa simultanea di paracetamolo, caffeina ed aspirina nelle compresse. Saggio limite quantitativo per l'acido salicilico. 992
Manuale di analisi qualitativa. Con e-book 706
Analisi Farmaceutica Qualitativa 525
1,3,4-Thiadiazole derivatives as antibacterial and antifungal agents. 408
Antimycobacterial activity of new 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues. 350
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations 321
A 3D-Pharmacophore Model for σ2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives 319
Improving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands 298
Stability of a novel Lidocaine, Adrenaline and Tetracaine sterile thermosensitive gel: A ready-to-use formulation 295
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 287
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 271
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. 270
DETERMINAZIONE QUANTITATIVA DI FENOBARBITALE, FENITOINA E MEFOBARBITALE NELLE COMPRESSE MEDIANTE HPLC. 269
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 265
Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands 262
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents 258
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site 255
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: preliminary data and computational analysis 255
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands 253
Antihypertensive activity of arylidenaminoguanidine derivatives. 246
Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment 244
Another Brick in the Wall. Validation of the σ1Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1Ligands 240
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation 239
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands 233
1-Substituted 3-(ω-aminoalkyl)-1H-indole derivatives as possibile s ligands. 231
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligand based on a series of benzo[d]oxazol-2(3H)-one derivatives 225
Antimycobacterial activities of N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones. 215
In-vitro antimycobacterial activity of new synthetic amidrazone derivatives 214
Potential antihypertensive agents. IV. Aminoguanidine and hydrazinopyrimidine derivatives. 212
Aminoguanidine and amidrazone derivatives, potential antihypertensive agents. 209
Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives 208
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor 206
Determinazione mediante HPLC dell'acido gentisico nelle urine di soggetti trattati con aspirina 204
2-PYRIDINCARBOXYAMIDRAZONE DERIVATIVES STRUCTURALLY RELATED TO AZOLE ANTIFUNGAL AGENTS. 203
SYNTHESIS AND ANTIMYCOBACTERIAL PROPERTIES OF AMIDRAZONE DERIVATIVES. 202
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 201
Antihypertensive activity of some 1,3,4-tiadiazole derivatives. 199
Exploring new structures in the development of new sigma ligands 198
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 196
Synthesis and antihypertensive activity of some aminoguanidine and amidrazone derivatives 195
Synthesis and antifungal activity of (9/)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives. 194
Antitubercular activity of a new pyridinecarboxamidrazone compound alone and in combination with reference drugs, by MRA and in a macrophage model. 193
Synthesis and antibacterial activity of aminoguanidine and amidrazone derivatives 187
Anti-tubercular acivity of new coumpounds 187
3D pharmacophore model of σ1 binding site based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. 185
Ion-pair liquid chromatographic assay of angiotensin-converting enzyme activity 184
2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds. Convetional heating in comparison with MW-assisted synthesis. 181
Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives 180
1-substituted-3-(o-aminoalkyl)-1H-indole derivatives as possible sigma ligands. 179
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation 178
PEGylation of coenzyme Q10 and in vitro release studies 175
Overview on σ1 receptor: a 3D homology model to solve a part of the enigma. 169
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. 169
null 168
Simultaneous quantitation of paracetamol, caffeine and propyphenazone by high-pressure liquid chromatography 164
Synthesis and antibacterial activity of aminoguanidine and amidrazone derivatives. 163
Design, synthesis and biological profile of new piperidine-4-carboxamide as effective sigma ligands 161
3-Piperidin-4-yl-methyl-3H-benzoxazol-2-one derivatives as sigma ligands. 160
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives 154
Antitubercular activity of novel 3-(2-oxo-2-arylethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ones derivatives 153
"Sintesi ed attività antimicobatterica di derivati 2-piridincarbossamidrazonici di 1-[4-(1H-imidazol-1-il)fenil]-3-arilpropanonni." 152
Benzoxazinones and correlated scaffolds linked to benzylamino moieties through a butylene spacer. New sigma receptor ligands 151
Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones 150
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2) 150
Synthesis and antifungal activity of some amidrazone derivatives 147
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 146
Synthesis and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 146
DETERMINAZIONE DELL’AMIODARONE E DEL DESETILAMIODARONE NEL SIERO UMANO MEDIANTE HPLC. 146
Determinazione quantitativa della carbamazepina nelle compresse mediante HPLC in fase inversa. 144
Substituted benzylaminoalkylindoles with preference for the σ2 binding site 143
DERIVATI AMIDRAZONICI E 1,2,4-TIADIAZOLICI AD ATTIVITÀ ANTIIPERTENSIVA. 143
The sigma-enigma. A multistep homology modeling of sigma1 receptors 142
DETERMINAZIONE QUANTITATIVA DI GUANABENZ E MEFRUSIDE MEDIANTE HPLC. 141
Synthesys and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 140
“Progettazione, sintesi e valutazione dell’attività antimicobatterica ed antifungina di nuovi derivati imidazolici e triazolici. Studio correlato di molecular modeling.” 140
Progettazione e sintesi di nuovi derivati bis-imidazolici ad attività antifungina ed antimicobatterica 140
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 137
SYNTHESIS, MOLECULAR MODELING AND EXPERIMENTALACTIVITY OF SOME NEW ACETAMIDE, BENZAMIDE ANDPHENYLMETHANONE DERIVATIVES AS SIGMA LIGANDS. 136
A new class of substituted benzo[d]oxazole-2(3H)-one derivatives as sigma1 ligands. 136
Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives 135
High-pressure liquid chromatographic analysis of paracetamol, caffeine and acetylsalicylic acid in tablets. Salicylic acid quantitation 135
Simultaneous determination of amiodarone and desethylamiodarone in human plasma by high-pressure liquid chromatography. 134
Simultaneous determination of phenobarbital, phenytoin and methylphenobarbital in tablet formulations by HPLC 133
Arylidene Derivatives of 4-Pyridincarboxamidrazone as Antimycobacterial Agents. 133
Synthesis and antimycobacterial properties of amidrazone derivatives (II) 133
Novel 1,4-Benzoxazin-3-One Derivatives as Potential Antitubercular Compounds Targeting MenB Enzyme 133
Rapporti tra struttura ed attività antibatterica in una serie di derivati aminoguanidinici. 132
Molecular modeling in drug design. New chemicals with antibacterial, antitubercular and antifungal activity: synthesis and MIC evaluatiotn. Experimental and computational approach. 132
Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands. 131
Benzossazol-2-oni e benzotiazol-2-oni come possibili ligandi sigma. 131
Synthesis and antimycobacterial activity of 5-aryl-1-isonicotynoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. 130
Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4-thiadiazole derivatives 129
Preliminary evaluation of in-vitro antimycobacterial properties of N1-(aryliden)-2-pyridincarboxamidrazones 128
“Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives.” Il Farmaco, 58 (2003) 631-637. 125
Synthesis and antimycobacterial activity of some indole derivatives of pyridine-2-carboxamidrazone and quinoline-2-carboxamidrazone 124
SYNTHESIS AND ANTIMYCOBACTERIAL PROPERTIES OF 2-PYRIDINCARBOXAMIDRAZONE DERIVATIVES. 124
ARYLIDENE DERIVATIVES OF 2- AND 4-PYRIDINCARBOXYAMIDRAZONE AS POSSIBILE ANTIMYCOBACTERIAL AGENTS. 124
Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives 122
Rapid HPLC analysis for quantitative determination of aristolochic acids 120
SYNTHESIS AND ANTIMYCOBACTERIAL PROPERTIES OF CYCLIC AMIDRAZONE DERIVATIVES. 118
Totale 20.299
Categoria #
all - tutte 77.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.797 0 0 127 369 45 177 136 78 235 182 116 332
2022/20232.770 212 252 175 295 269 469 40 223 301 334 132 68
2023/20241.507 111 76 120 105 218 129 150 240 43 86 131 98
2024/20252.764 55 68 105 242 276 403 126 195 360 275 288 371
2025/20267.295 589 444 773 708 548 750 1.004 264 788 1.009 260 158
2026/20271.071 233 404 434 0 0 0 0 0 0 0 0 0
Totale 27.457